JCB logo
CountessT Automated Cell Counter
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.200801099
The Journal of Cell Biology, Vol. 183, No. 1, 101-116
The Rockefeller University Press, 0021-9525 $30.00
© Degtyarev et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 8184K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Degtyarev, M.
Right arrow Articles by Lin, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Degtyarev, M.
Right arrow Articles by Lin, K.
Related Collections
Right arrowRelated In this Issue article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents



Michael Degtyarev1, Ann De Mazière2, Christine Orr1, Jie Lin1, Brian B. Lee1, Janet Y. Tien1, Wei W. Prior1, Suzanne van Dijk2, Hong Wu3, Daniel C. Gray1, David P. Davis1, Howard M. Stern1, Lesley J. Murray1, Klaus P. Hoeflich1, Judith Klumperman2, Lori S. Friedman1, and Kui Lin1

1 Genentech, Inc., South San Francisco, CA 94080
2 Cell Microscopy Center, Department of Cell Biology and Institute for Biomembranes, University Medical Center Utrecht, 3584 CX Utrecht, Netherlands
3 Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095

Correspondence to Kui Lin: klin{at}gene.com

Although Akt is known as a survival kinase, inhibitors of the phosphatidylinositol 3-kinase (PI3K)–Akt pathway do not always induce substantial apoptosis. We show that silencing Akt1 alone, or any combination of Akt isoforms, can suppress the growth of tumors established from phosphatase and tensin homologue–null human cancer cells. Although these findings indicate that Akt is essential for tumor maintenance, most tumors eventually rebound. Akt knockdown or inactivation with small molecule inhibitors did not induce significant apoptosis but rather markedly increased autophagy. Further treatment with the lysosomotropic agent chloroquine caused accumulation of abnormal autophagolysosomes and reactive oxygen species, leading to accelerated cell death in vitro and complete tumor remission in vivo. Cell death was also promoted when Akt inhibition was combined with the vacuolar H+–adenosine triphosphatase inhibitor bafilomycin A1 or with cathepsin inhibition. These results suggest that blocking lysosomal degradation can be detrimental to cancer cell survival when autophagy is activated, providing rationale for a new therapeutic approach to enhancing the anticancer efficacy of PI3K–Akt pathway inhibition.

C. Orr and J. Lin contributed equally to this paper.

D. Gray's present address is Chemistry and Biology Graduate Program, University of California, San Francisco, San Francisco, CA 94158.

Abbreviations used in this paper: AO, acridine orange; AV, autophagic vacuole; AVO, acidic vesicular organelle; Ba, bafilomycin A1; CCD, charge-coupled device; CQ, chloroquine; Dox, doxycycline; IHC, immunohistochemistry; KD, knockdown; LAMP, lysosome-associated membrane protein; MDC, monodansylcadaverine; MEF, mouse embryonic fibroblast; mTOR, mammalian target of rapamycin; NAC, N-acetylcysteine; PARP, poly-ADP-ribose polymerase; PI, propidium iodide; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase and tensin homologue; ROS, reactive oxygen species; shAkt, Akt-targeting shRNA; shRNA, short hairpin RNA.

© 2008 Degtyarev et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related In this Issue article

Autophagy inhibitors deliver a knock-out blow
Richard Robinson
J. Cell Biol. 2008 183: 2-3. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents